Skip to content
Governance Register

← US public companies

Kaleido Biosciences, Inc.

SEC CIK 1751299 · KLDO · last insider filing 2022-03-02

Directors (from insider filings)

NameCapacity as filedFilings
Menichella Daniel L Director · Chief Executive Officer filed 2020 - 2022
Melas Kyriazi Theo Director filed 2019 - 2021
Bonney Michael W Director · Executive Chair filed 2019 - 2021
Quinn Anthony G. Director filed 2019 - 2021
Mixer Jean K Director filed 2019 - 2021
Bassler Bonnie L Director filed 2019 - 2021
Burnett Grady Director filed 2019 - 2021
von Maltzahn Geoffrey Director filed 2019 - 2021
Prener Anne Director filed 2020 - 2021
Afeyan Noubar Director filed 2019 - 2021
Flagship Ventures Fund IV General Partner LLC Director filed 2019 - 2021
Lawton Alison Frances Director · See Remarks filed 2019 - 2020
Flagship Ventures Fund V General Partner LLC Director filed 2019 - 2019
Sculley John Director filed 2019 - 2019
Mcintyre Jonathan Director filed 2019 - 2019

Officers (from insider filings)

NameTitle as filedFilings
Korn Jerald General Counsel filed 2019 - 2022
van Hylckama Vlieg Johan Chief Scientific Officer filed 2021 - 2022
Duke William E. Chief Financial Officer filed 2019 - 2022
Long Alison S Chief Medical Officer filed 2021 - 2022
Knobil Katharine See Remarks filed 2019 - 2020
Scalzo Richard William Principal Accounting Officer filed 2019 - 2019
Brumm Joshua T See Remarks filed 2019 - 2019

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.